A structural model of the HIV-1 Rev-integrase complex: The molecular basis of integrase regulation by Rev

Biochemical and Biophysical Research Communications

Volumn 416, Issue 3-4, 2011, Pages 252-257

  Benyamini, Hadar ^a   Loyter, Abraham ^a   Friedler, Assaf ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Docking; HIV 1; Integrase; Modeling; Peptides; Protein protein interaction; Rev

Indexed keywords

DIMER; DNA POLYMERASE REV1; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; MONOMER; MULTIPROTEIN COMPLEX; TETRAMER; VIRUS DNA;

ARTICLE; BINDING KINETICS; ENZYME REGULATION; EQUILIBRIUM CONSTANT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INHIBITION KINETICS; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANTI-HIV AGENTS; DRUG DISCOVERY; HIV INTEGRASE; HUMANS; MODELS, CHEMICAL; PROTEIN CONFORMATION; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84855879701     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.116     Document Type: Article

References (34)

1. Levin A., Rosenbluh J., Hayouka Z., Friedler A., Loyter A. Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins. Mol. Med. 2010, 16:34-44.
2. Levin A., Hayouka Z., Friedler A., Loyter A. Specific eradication of HIV-1 from infected cultured cells. AIDS Res. Ther. 2010, 7:31.
3. Rosenbluh J., Hayouka Z., Loya S., Levin A., Armon-Omer A., Britan E., Hizi A., Kotler M., Friedler A., Loyter A. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J. Biol. Chem. 2007, 282:15743-15753.
4. Levin A., Hayouka Z., Helfer M., Brack-Werner R., Friedler A., Loyter A. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration. PLoS One 2009, 4:e4155.
5. Levin A., Hayouka Z., Brack-Werner R., Volsky D.J., Friedler A., Loyter A. Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration. Protein Eng. Des. Sel. 2009, 22:753-763.
6. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 2002, 8:673-680.
7. Van Maele B., Debyser Z. HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev 2005, 7:26-43.
8. Engelman A. Reverse transcription and integration. Retroviruses: Molecular Biology, Genomics and Pathogenesis 2010, 129-159. Caister Academic Press, Norfolk, UK. R. Kurth, N. Bannert (Eds.).
9. Pommier Y., Johnson A.A., Marchand C. Integrase inhibitors to treat HIV/AIDS. Nat. Rev. Drug Discov. 2005, 4:236-248.
10. De Luca L., De Grazia S., Ferro S., Gitto R., Christ F., Debyser Z., Chimirri A. HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation. Eur. J. Med. Chem. 2011, 46:756-764.
11. Delelis O., Carayon K., Saib A., Deprez E., Mouscadet J.F. Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology 2008, 5:114.
12. Serrao E., Odde S., Ramkumar K., Neamati N. Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology 2009, 6:25.
13. Steigbigel R.T., Cooper D.A., Kumar P.N., Eron J.E., Schechter M., Markowitz M., Loutfy M.R., Lennox J.L., Gatell J.M., Rockstroh J.K., Katlama C., Yeni P., Lazzarin A., Clotet B., Zhao J., Chen J., Ryan D.M., Rhodes R.R., Killar J.A., Gilde L.R., Strohmaier K.M., Meibohm A.R., Miller M.D., Hazuda D.J., Nessly M.L., DiNubile M.J., Isaacs R.D., Nguyen B.Y., Teppler H. Raltegravir with optimized background therapy for resistant HIV-1 infection. N. Engl. J. Med. 2008, 359:339-354.
14. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52:491-532.
15. Li L., Li H.S., Pauza C.D., Bukrinsky M., Zhao R.Y. Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res. 2005, 15:923-934.
16. Iyer S.R., Yu D., Biancotto A., Margolis L.B., Wu Y. Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates. J. Virol. 2009, 83:8662-8673.
17. Levin A., Hayouka Z., Helfer M., Brack-Werner R., Friedler A., Loyter A. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein. Biopolymers 2010, 93:740-751.
18. Hayouka Z., Rosenbluh J., Levin A., Maes M., Loyter A., Friedler A. Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism. Biopolymers 2008, 90:481-487.
19. Llano M., Saenz D.T., Meehan A., Wongthida P., Peretz M., Walker W.H., Teo W., Poeschla E.M. An essential role for LEDGF/p75 in HIV integration. Science 2006, 314:461-464.
20. Emiliani S., Mousnier A., Busschots K., Maroun M., Van Maele B., Tempe D., Vandekerckhove L., Moisant F., Ben-Slama L., Witvrouw M., Christ F., Rain J.C., Dargemont C., Debyser Z., Benarous R. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem. 2005, 280:25517-25523.
21. Maertens G., Cherepanov P., Pluymers W., Busschots K., De Clercq E., Debyser Z., Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 2003, 278:33528-33539.
22. Mashiach E., Nussinov R., Wolfson H.J. FiberDock: Flexible induced-fit backbone refinement in molecular docking. Proteins 2010, 78:1503-1519.
23. Camacho C.J., Zhang C. FastContact: rapid estimate of contact and binding free energies. Bioinformatics 2005, 21:2534-2536.
24. Alva V., Devi D.P., Sowdhamini R. Coil check: an interactive server for the analysis of interface regions in coiled coils. Protein Pept. Lett. 2008, 15:33-38.
25. Cherepanov P., Ambrosio A.L., Rahman S., Ellenberger T., Engelman A. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. USA 2005, 102:17308-17313.
26. Wang J.Y., Ling H., Yang W., Craigie R. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. Embo J. 2001, 20:7333-7343.
27. Hare S., Gupta S.S., Valkov E., Engelman A., Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010, 464:232-236.
28. Duhovny D., Nussinov R., Wolfson H.J. Efficient unbound docking of rigid molecules. Workshop on Algorithms in Bioinformatics 2002, 185-200. LNCS, Rome, Italy. R. Guigo, D. Gusfield (Eds.).
29. Schneidman-Duhovny D., Inbar Y., Polak V., Shatsky M., Halperin I., Benyamini H., Barzilai A., Dror O., Haspel N., Nussinov R., Wolfson H.J. Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins 2003, 52:107-112.
30. D. Schneidman-Duhovny, Y. Inbar, R. Nussinov, H.J. Wolfson, PatchDock and SymmDock: servers for rigid and symmetric docking, Nucleic Acids Res 33 (2005) W363-367. http://bioinfo363d.cs.tau.ac.il.
31. Zhang C., Vasmatzis G., Cornette J.L., DeLisi C. Determination of atomic desolvation energies from the structures of crystallized proteins. J. Mol. Biol. 1997, 267:707-726.
32. Cherepanov P., Sun Z.Y., Rahman S., Maertens G., Wagner G., Engelman A. Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat. Struct. Mol. Biol. 2005, 12:526-532.
33. DiMattia M.A., Watts N.R., Stahl S.J., Rader C., Wingfield P.T., Stuart D.I., Steven A.C., Grimes J.M. Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element. Proc Natl Acad Sci U S A 2010, 107:5810-5814.
34. Mashiach E., Nussinov R., Wolfson H.J. FiberDock: a web server for flexible induced-fit backbone refinement in molecular docking. Nucleic Acids Res. 2010, 38:W457-W461.